In a sarcoma model using anti-CD3 activated TDLN, CD8 cells caused tumor regression while CD4 cells did not result in tumor regression but instead provided a helper function to CD8 cells that could be replaced with exogenous IL-2 [13]. This evidence concerns the gene CD4 and neoplasm.